Sign in
Active, not recruitingNo phase

Minds and Mentors Program- R33

Key facts

Who runs it
University of Alabama, Tuscaloosa
Where
Birmingham and Tuscaloosa, United StatesSee the 4 sites
Trial code
Status
Active, not recruiting
People taking part
240 people, planned
Started
4 Jan 2022
Expected to end
31 May 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Minds and Mentors
  • Twelve Step Intervention Group
Record updated
6 May 2026

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Age 19 and older
  • Opioid Use disorder diagnosis based on DSM-V criteria in the past 30 days
  • Currently receiving MOUD (e.g. methadone, naloxone, naltrexone, and buprenorphine) from an established provider
  • Are within maintenance phase of MOUD (not actively detoxing)
  • May meet criteria for a mood, anxiety, or other psychiatric disorder based on the DSM-V criteria. Participants on maintenance medications for a mood or anxiety disorder must be stabilized on medications for at least 2 weeks before therapy initiation
  • Capable of reading and understanding English
  • Able to provide written informed consent (i.e. no surrogate)
  • Access to a smartphone or a computer with an internet connection
  • Willing to commit to 12 group therapy sessions, baseline, and follow-up assessments for 24 weeks after the end of treatment (9- month total)

Who cannot take part

  • Increases in alcohol or drug use leading to the need for a more intensive level of care (i.e., medical detoxification, inpatient)
  • Inability to return for therapy sessions for four consecutive weeks
  • Significant cognitive impairment
  • Unstable medical conditions that contraindicate proposed treatment; Subject Exit criteria:
  • Inability to manage psychiatric symptoms within the inclusion/exclusion criteria of the study (i.e., need for the initiation of maintenance psychotropic medications; development of psychosis). If it is determined, based on clinical criteria, that a participant needs to be started on maintenance medications for anxiety, mood or psychotic symptoms during the study, they will be discontinued from the treatment trial
  • Women who are pregnant (does not impact eligibility post study initiation)
  • Actively suicidal or homicidal
  • Active psychosis and/ or
  • Newly developed active suicidal or homicidal ideation

Where in United States

  • Birmingham Veteran Affairs Medical CenterBirmingham, United States
  • Pathway Healthcare, LLCBirmingham, United States
  • Tuscaloosa Veteran Affairs Medical CenterTuscaloosa, United States
  • University of AlabamaTuscaloosa, United States

About the trial

What the trial wants to find out

The proposed research effort will:

Read full original descriptionShow less

The purpose of this study is as follows:

1. Test the effectiveness of the Minds and Mentors Program in a group treatment trial in which individuals using medications for opioid use disorder (MOUD) will be randomized in blocks of five to receive either the Minds and Mentors Program (n=120) or Twelve Step Facilitation (n=120). 2. Determine whether the MiMP: a) improves adherence to MOUD b) reduces the rate of relapse and cravings c) decreases self-reported anxiety, stress, and depression and d) reduces cortisol levels and cortisol reactivity to drug cues. 3. Examine whether pre-intervention cortisol reactivity is predictive of relapse outcomes, and/ or reductions in cortisol reactivity over the course of intervention mediate relapse outcomes.

The 2 groups in the trial

  • Mindfulness based relapse prevention and peer mentoringTreatment being tested

    Treatment will utilize a group format. The twelve-week mindfulness based relapsed prevention group therapy intervention is co-led by a licensed counselor and a peer mentor for eight weeks, followed by group sessions led by peer mentors for an additional four weeks.

    Treatment: Minds and Mentors

  • 12 Step Treatment ProgramExisting treatment, for comparison

    Participants in the attentional control group will attend 12 weeks of a enhanced 12 step treatment program.

    Treatment: Twelve Step Intervention Group

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Mindfulness and Peer Mentoring Program to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R33 Phase)
Record updated
6 May 2026